Publications & Multimedia

Cochrane reviews

Cochrane Reviews from READ-It Partners in the Cochrane Database of Systematic Reviews.

Supporting materials

Guidelines

Multimedia resources

Reports

Other publications and stories

View all resources

1

Latest resources

Tafenoquine for preventing relapse in people with Plasmodium vivax malaria

The aim of this review was to see if tafenoquine could prevent relapses of vivax infections and if this effect is equivalent to that of standard‐dose primaquine.

Cochrane Systematic Review: UPDATE

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children

The aim of this review is to determine the accuracy of tests in symptomatic children for diagnosing pulmonary tuberculosis, tuberculous meningitis, lymph node tuberculosis, and rifampicin resistance.

Cochrane Systematic Review: NEW

1

Tafenoquine for preventing relapse in people with Plasmodium vivax malaria

The aim of this review was to see if tafenoquine could prevent relapses of vivax infections and if this effect is equivalent to that of standard‐dose primaquine.

Cochrane Systematic Review: UPDATE

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children

The aim of this review is to determine the accuracy of tests in symptomatic children for diagnosing pulmonary tuberculosis, tuberculous meningitis, lymph node tuberculosis, and rifampicin resistance.

Cochrane Systematic Review: NEW

Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

How accurate are rapid tests, performed during a health‐care visit (point‐of‐care), for diagnosing COVID‐19?

Cochrane Systematic Review: NEW

Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax

Primaquine to cure people with Plasmodium vivax malaria: comparing dosing schedules

Cochrane Systematic Review: UPDATE

Community‐level interventions for improving access to food in low‐ and middle‐income countries

This Cochrane Review looked at the effect of community-level interventions on individuals, households and communities in LMICs to improve access to nutritious food

Cochrane Systematic Review: NEW

New ARRIVE Guidelines 2.0 released

Better reporting of animal research is the aim of the ARRIVE Guidelines. LSTM’s Professor Paul Garner has been part of a team of senior researchers and science editors that have updated guidelines for the reporting of research and methods in scientific studies in animals.

Dissemination products

Podcast: Can symptoms and medical examination accurately diagnose COVID-19 disease?

In this podcast, lead author, Thomas Struyf from the KU Leuven in Belgium, explains why this review is needed and discusses the findings of the review.

Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19 disease

This review assesses the diagnostic accuracy of signs and symptoms to determine if a person presenting in primary care or to hospital outpatient settings, has COVID‐19 disease or COVID‐19 pneumonia.

Cochrane Systematic Review: NEW

WHO consolidated guidelines on tuberculosis Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection

This document consolidates five guidelines developed by WHO between 2016 and 2020.

Dissemination products

Rapid diagnostic tests for plague

A rapid diagnostic test (RDT) could help prompt diagnosis of plague, especially in low‐resource settings.

Cochrane Systematic Review: NEW

Antibody tests for identification of current and past infection with SARS‐CoV‐2

Antibody tests could have a useful role in detecting if someone has had COVID-19, but timing is important.

Cochrane Systematic Review: NEW

Should healthcare personnel in nursing homes without respiratory symptoms wear facemasks for primary prevention of COVID-19? A rapid review

Internationally, there are conflicting recommendations regarding the use of facemasks by asymptomatic personnel in long-term care facilities for primary prevention (when no cases have yet been identified) of COVID-19 infection.

Peer-reviewed article

Pages